Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_1
3
100%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 13 (100.0%)

Trials by Status

not_yet_recruiting3100%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_1

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT07107204
not_yet_recruitingphase_1

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

NCT07110363
not_yet_recruitingphase_1

A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma

NCT07107178

Clinical Trials (3)

Showing 3 of 3 trials
NCT07107204Phase 1

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

Not Yet Recruiting
NCT07110363Phase 1

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

Not Yet Recruiting
NCT07107178Phase 1

A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma

Not Yet Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3